As of 2025-09-08, the Relative Valuation of Sino Biopharmaceutical Ltd (1177.HK) is 3.08 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 8.91 HKD, the upside of Sino Biopharmaceutical Ltd based on Relative Valuation is -65.5%.
The range of the Relative Valuation is 2.46 - 3.69 HKD.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.5x | 12.0x |
| Forward P/E multiples | 10.4x - 12.7x | 11.8x |
| Fair Price | 2.46 - 3.69 | 3.08 |
| Upside | -72.4% - -58.6% | -65.5% |
| Date | P/E |
| 2025-09-05 | 39.50 |
| 2025-09-04 | 37.20 |
| 2025-09-03 | 38.26 |
| 2025-09-02 | 37.64 |
| 2025-09-01 | 38.17 |
| 2025-08-29 | 35.96 |
| 2025-08-28 | 34.32 |
| 2025-08-27 | 35.07 |
| 2025-08-26 | 36.80 |
| 2025-08-25 | 37.06 |
| 2025-08-22 | 36.22 |
| 2025-08-21 | 34.23 |
| 2025-08-20 | 33.07 |
| 2025-08-19 | 32.76 |
| 2025-08-18 | 35.07 |
| 2025-08-15 | 34.67 |
| 2025-08-14 | 33.78 |
| 2025-08-13 | 34.18 |
| 2025-08-12 | 33.21 |
| 2025-08-11 | 32.94 |
| 2025-08-08 | 32.63 |
| 2025-08-07 | 32.32 |
| 2025-08-06 | 33.25 |
| 2025-08-05 | 33.16 |
| 2025-08-04 | 32.14 |
| 2025-08-01 | 32.45 |
| 2025-07-31 | 33.34 |
| 2025-07-30 | 33.34 |
| 2025-07-29 | 33.47 |
| 2025-07-28 | 32.14 |
| 2025-07-25 | 30.02 |
| 2025-07-24 | 29.75 |
| 2025-07-23 | 29.66 |
| 2025-07-22 | 30.59 |
| 2025-07-21 | 30.50 |
| 2025-07-18 | 30.59 |
| 2025-07-17 | 30.24 |
| 2025-07-16 | 28.55 |
| 2025-07-15 | 28.24 |
| 2025-07-14 | 26.91 |
| 2025-07-11 | 26.29 |
| 2025-07-10 | 26.25 |
| 2025-07-09 | 26.20 |
| 2025-07-08 | 23.81 |
| 2025-07-07 | 24.38 |
| 2025-07-04 | 24.83 |
| 2025-07-03 | 24.16 |
| 2025-07-02 | 23.63 |
| 2025-06-30 | 23.32 |
| 2025-06-27 | 23.50 |